Among 76 anti-gp20- and/or anti-p62- and/or anti-LBR-positive PBC patients, 21% were classified into stages I/II, and 79% into stages III/IV, according to Ludwig’s classification (Figure 10). This evidence concerns the gene LBR and primary biliary cholangitis.